✦ LIBER ✦

Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial

✍ Scribed by Tim Eisen; Heikki Joensuu; Paul D Nathan; Peter G Harper; Marek Z Wojtukiewicz; Steve Nicholson; Amit Bahl; Piotr Tomczak; Seppo Pyrhonen; Kate Fife; Petri Bono; Jane Boxall; Andrea Wagner; Michael Jeffers; Tiffany Lin; David I Quinn

Book ID: 119608999
Publisher: The Lancet
Year: 2012
Tongue: English
Weight: 231 KB
Volume: 13
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(12)70364-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 2 trial of talactoferrin in previo

Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma

✍ Eric Jonasch; Walter M. Stadler; Ronald M. Bukowski; Teresa G. Hayes; Atul Varad 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

## Abstract ## BACKGROUND. Talactoferrin (TLF), a recombinant form of human lactoferrin (hLF), is an immunomodulatory iron‐binding glycoprotein first identified in breast milk. Its immunomodulatory functions include activation of natural killer (NK) and lymphokine‐activated killer cells and enhanc

7141 POSTER Phase II Trial of the Oral M

7141 POSTER Phase II Trial of the Oral Multikinase Inhibitor Regorafenib (BAY 73-4506) as First-line Therapy in Patients With Metastatic or Unresectable Renal Cell Carcinoma (RCC)

✍ Eisen, T.; Joensuu, H.; Nathan, P.; Harper, P.; Wojtukiewicz, M.; Nicholson, S.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

A new prognostic classification for over

A new prognostic classification for overall survival in Asian patients with previously untreated metastatic renal cell carcinoma

✍ Nobuo Shinohara; Katsuya Nonomura; Takashige Abe; Satoru Maruyama; Takao Kamai; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB

Phase I trial of sorafenib in combinatio

Phase I trial of sorafenib in combination with interferon-alpha in Japanese patients with unresectable or metastatic renal cell carcinoma

✍ Masashi Niwakawa, Katsuyoshi Hashine, Raizo Yamaguchi, Hirofumi Fujii, Yasuo Ham 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 359 KB

Phase 2 trial of linifanib (ABT-869) in

Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma

✍ Han Chong Toh; Pei-Jer Chen; Brian I. Carr; Jennifer J. Knox; Sharlene Gill; Pet 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 958 KB

Phase II Trial of Pyrazoloacridine as Se

Phase II Trial of Pyrazoloacridine as Second-Line Therapy for Patients with Unresectable or Metastatic Transitional Cell Carcinoma

✍ Paul M. Dodd; John A. McCaffrey; Madhu Mazumdar; Evelyn Icasiano; Geralyn Higgin 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 50 KB